Patheon

Thermo Fisher Moves Into Drug Manufacturing
Strategy

Thermo Fisher Moves Into Drug Manufacturing

The $5.2 billion acquisition of Patheon positions Thermo Fisher to grab a slice of the fast-growing contract drug production business.
By Matthew Heller | May 15, 2017
Read More